Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan
**Background:** The role of platinum rechallenge in head and neck cancer (HNC) has not yet been fully evaluated. **Objectives:** It is our goal to assess the real-world treatment patterns and usefulness of platinum rechallenge in patients with platinum-refractory recurrent or metastatic HNC receivi...
Saved in:
Main Authors: | Makoto Tahara, Issei Doi, Tatsunori Murata, Sari Mishina, Shinji Takai, Hirokazu Kaneko |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2020-05-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/jheor.2020.12853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma
by: Yu Ishizuya, et al.
Published: (2025-02-01) -
Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01) -
Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer
by: Danielle S. Lewis, et al.
Published: (2025-02-01) -
The Hippo pathway promotes platinum-based chemotherapy by inhibiting MTF1-dependent heavy metal response
by: Hui Chen, et al.
Published: (2025-02-01) -
Choice and justification of the method of titanium welding with platinum
by: Anatolii Sanin, et al.
Published: (2024-06-01)